Enzychem Lifesciences Corporation (KOSDAQ:183490)

South Korea · Delayed Price · Currency is KRW

1,045.00

+23.00 (2.25%)

Mar 12, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Raw Drug Product Division	32.17B	34.18B	25.63B	21.60B	24.99B
Raw Drug Product Division Growth	-5.90%	33.36%	18.64%	-13.54%	-19.97%
Health Functional Food Division	2.01B	930.87M	1.01B	1.37B	831.28M
Health Functional Food Division Growth	115.47%	-7.58%	-26.55%	64.96%	86.18%
Bio-Maintenance Sector	43.21B	40.93B	-	-	-
Bio-Maintenance Sector Growth	5.57%	-	-	-	-
Total	77.38B	76.04B	26.64B	22.98B	25.82B
Total Growth	1.76%	185.46%	15.94%	-11.01%	-17.96%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	71.06B	70.91B	23.87B	21.87B	23.72B
South Korea Growth	0.22%	197.08%	9.15%	-7.82%	-16.38%
Overseas	6.32B	5.13B	2.77B	1.11B	2.10B
Overseas Growth	23.08%	85.30%	149.76%	-47.10%	-32.34%
Total	77.38B	76.04B	26.64B	22.98B	25.82B
Total Growth	1.76%	185.46%	15.94%	-11.01%	-17.96%

Source: S&P Global Market Intelligence.